New COVID-19 Vaccines Show Strong Protection for Young Children—Here's What Parents Need to Know

The latest COVID-19 vaccines are delivering strong protection for children, with new CDC data showing 76% effectiveness against emergency department visits in young children aged 9 months to 4 years, and 56% effectiveness in children and adolescents aged 5 to 17 years. This real-world evidence comes from a comprehensive study tracking vaccine performance across nine states during the 2024-2025 season.

How Effective Are the New COVID-19 Vaccines for Kids?

The Centers for Disease Control and Prevention (CDC) analyzed data from the Virtual SARS-CoV-2, Influenza, and Other respiratory viruses Network (VISION), which tracks vaccine effectiveness across 256 emergency departments and urgent care centers. The study examined children who visited these facilities between August 29, 2024, and September 2, 2025, comparing those who received the updated vaccine to those who didn't.

For the youngest children—those aged 9 months to 4 years—the vaccine showed particularly impressive results, preventing about three out of every four emergency visits related to COVID-19. Older children and teens still received substantial protection, with the vaccine preventing more than half of potential emergency visits.

What Makes These Vaccines Different?

The 2024-2025 COVID-19 vaccines were specifically designed to target the Omicron JN.1 strain and its related variants, which became the dominant circulating viruses during 2024. This represents a significant update from the previous year's vaccines, which were based on the older XBB lineages that had become less common.

The vaccination recommendations vary by age group:

• Previously Unvaccinated Young Children: Those aged 6 months to 4 years need multiple doses—either 3 doses of the Pfizer-BioNTech vaccine or 2 doses of the Moderna vaccine
• Previously Vaccinated Young Children: Those who completed an initial series need just one 2024-2025 dose
• Children 5 and Older: All children in this age group need only a single 2024-2025 dose, regardless of their vaccination history

Why This Protection Matters for Families?

COVID-19 continues to cause significant illness in children, with approximately 38,000 hospitalizations among children and adolescents under 18 years occurring during September 2023 through August 2024. This translates to about 53 hospitalizations per 100,000 children, with the youngest children facing the highest risk—600 hospitalizations per 100,000 children under 6 months of age.

The study's findings are particularly encouraging because they reflect real-world conditions where many children already had some level of protection from previous vaccinations, previous infections, or both. Even in this population with existing immunity, the updated vaccines provided meaningful additional protection against severe outcomes requiring emergency care.

Parents should note that in May 2025, health officials updated guidance to emphasize shared clinical decision-making between parents and healthcare providers for COVID-19 vaccination in healthy children and adolescents aged 6 months to 17 years. This means families can work with their pediatricians to determine the best vaccination approach based on their child's individual health status and risk factors.